BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29338557)

  • 21. Synthesis and characterization of PVK/AgNPs nanocomposites prepared by laser ablation.
    Abd El-Kader FH; Hakeem NA; Elashmawi IS; Menazea AA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():331-9. PubMed ID: 25506650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs.
    Franco AM; Grafova I; Soares FV; Gentile G; Wyrepkowski CD; Bolson MA; Sargentini É; Carfagna C; Leskelä M; Grafov A
    Int J Nanomedicine; 2016; 11():6771-6780. PubMed ID: 28008252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of silver nanoparticles in the rat lung: Influence of dose, size, and chemical composition.
    Anderson DS; Silva RM; Lee D; Edwards PC; Sharmah A; Guo T; Pinkerton KE; Van Winkle LS
    Nanotoxicology; 2015; 9(5):591-602. PubMed ID: 25231189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biogenic silver nanoparticles inducing Leishmania amazonensis promastigote and amastigote death in vitro.
    Fanti JR; Tomiotto-Pellissier F; Miranda-Sapla MM; Cataneo AHD; Andrade CGTJ; Panis C; Rodrigues JHDS; Wowk PF; Kuczera D; Costa IN; Nakamura CV; Nakazato G; Durán N; Pavanelli WR; Conchon-Costa I
    Acta Trop; 2018 Feb; 178():46-54. PubMed ID: 29111137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of different parameters under ultrasound irradiation for synthesis of new nanostructured Fe
    Abazari R; Mahjoub AR; Molaie S; Ghaffarifar F; Ghasemi E; Slawin AMZ; Carpenter-Warren CL
    Ultrason Sonochem; 2018 May; 43():248-261. PubMed ID: 29555282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects.
    Mostafavi M; Sharifi I; Farajzadeh S; Khazaeli P; Sharifi H; Pourseyedi E; Kakooei S; Bamorovat M; Keyhani A; Parizi MH; Khosravi A; Khamesipour A
    Biomed Pharmacother; 2019 Aug; 116():108942. PubMed ID: 31152929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO/IR/75/ER).
    Mohtasebi S; Mohebali M; Elikaee S; Akhoundi B; Foroushani AR; Teimouri A; Yarizadeh H
    Parasitol Res; 2019 Sep; 118(9):2669-2678. PubMed ID: 31278518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis.
    Lanza JS; Fernandes FR; Corrêa-Júnior JD; Vilela JM; Magalhães-Paniago R; Ferreira LA; Andrade MS; Demicheli C; Melo MN; Frézard F
    Int J Nanomedicine; 2016; 11():2305-18. PubMed ID: 27307731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
    Kalat SA; Khamesipour A; Bavarsad N; Fallah M; Khashayarmanesh Z; Feizi E; Neghabi K; Abbasi A; Jaafari MR
    Exp Parasitol; 2014 Aug; 143():5-10. PubMed ID: 24780938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macías I; Olmo F; Sanz AM; Campayo L; Cano C; Yunta MJ
    J Antimicrob Chemother; 2012 Feb; 67(2):387-97. PubMed ID: 22127582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antibacterial activity of ceramsite coated by silver nanoparticles in micropore.
    Qiu S; Huang X; Xu S; Ma F
    Appl Biochem Biotechnol; 2015 May; 176(1):267-76. PubMed ID: 25820386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells.
    Yuan YG; Gurunathan S
    Int J Nanomedicine; 2017; 12():6537-6558. PubMed ID: 28919753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity- and differentiation-mediated cancer therapy.
    Han JW; Gurunathan S; Choi YJ; Kim JH
    Int J Nanomedicine; 2017; 12():7529-7549. PubMed ID: 29066898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced graphene oxide-silver nanoparticle nanocomposite: a potential anticancer nanotherapy.
    Gurunathan S; Han JW; Park JH; Kim E; Choi YJ; Kwon DN; Kim JH
    Int J Nanomedicine; 2015; 10():6257-76. PubMed ID: 26491296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in Vitro Effect of Polyvinylpyrrolidone and Citrate Coated Silver Nanoparticles on Erythrocytic Oxidative Damage and Eryptosis.
    Ferdous Z; Beegam S; Tariq S; Ali BH; Nemmar A
    Cell Physiol Biochem; 2018; 49(4):1577-1588. PubMed ID: 30223265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileishmanial, cellular mechanisms, and cytotoxic effects of green synthesized zinc nanoparticles alone and in combined with glucantime against Leishmania major infection.
    Ghasemian Yadegari J; Khudair Khalaf A; Ezzatkhah F; Shakibaie M; Mohammadi HR; Mahmoudvand H
    Biomed Pharmacother; 2023 Aug; 164():114984. PubMed ID: 37321058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.